Resminostat (4SC-201) in Relapsed or Refractory Hodgkin's Lymphoma

NCT01037478 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

4SC AG